Gilberto Santos Cerqueira

Gilberto Santos Cerqueira

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2011 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
NRNayrton Flávio Moura Rocha
Nayrton Flávio Moura Rocha
EREmiliano Ricardo Vasconcelos Rios
Emiliano Ricardo Vasconcelos Rios
ACAlyne Mara Rodrigues Carvalho
Alyne Mara Rodrigues Carvalho
GCGilberto Santos Cerqueira
Gilberto Santos Cerqueira
ALAmanda de Araújo Lopes
Amanda de Araújo Lopes
FSFrancisca Cléa Florenço de Sousa
Francisca Cléa Florenço de Sousa

1 May 2012 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GCGilberto Santos Cerqueira
Gilberto Santos Cerqueira
GSGabriela dos Santos e Silva
Gabriela dos Santos e Silva
EVEmiliano Rios Vasconcelos
Emiliano Rios Vasconcelos
AFAna Paula Fragoso de Freitas
Ana Paula Fragoso de Freitas
BMBrinell Arcanjo Moura
Brinell Arcanjo Moura
GVGlauce Socorro de Barros Viana
Glauce Socorro de Barros Viana

1 October 2010 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
EREmiliano Ricardo Vasconcelos Rios
Emiliano Ricardo Vasconcelos Rios
NRNayrton Flávio Moura Rocha
Nayrton Flávio Moura Rocha
EVEdith Teles Venâncio
Edith Teles Venâncio
BMBrinell Arcanjo Moura
Brinell Arcanjo Moura
MFMariana Lima Feitosa
Mariana Lima Feitosa
MFMarta Maria de França Fonteles
Marta Maria de França Fonteles

17 June 2020 in Molecules
Verified
Journal Article
Open access
PDF file
LFLazaro de Sousa Fideles
Lazaro de Sousa Fideles
JMJoão De Miranda
João De Miranda
CMConceição da Silva Martins
Conceição da Silva Martins
MBMaria Lucianny Lima Barbosa
Maria Lucianny Lima Barbosa
HPHELDER PIMENTA
HELDER PIMENTA
GCGilberto Santos Cerqueira
Gilberto Santos Cerqueira
Intestinal mucositis, characterized by inflammatory and/or ulcerative processes in the gastrointestinal tract, occurs due to cellular and tissue damage following treatment with 5-fluorouracil (5-FU). Rutin (RUT), a natural flavonoid extracted from Dimorphandra gardneriana, exhibits antioxidant, anti-inflammatory, cytoprotective, and gastroprotective properties. However, the effect of RUT on inflammatory processes in the intestine, especially on mucositis promoted by antineoplastic agents, has not yet been reported. In this study, we investigated the role of RUT on 5-FU-induced experimental intestinal mucositis. Swiss mice were randomly divided into seven groups: Saline, 5-FU, RUT-50, RUT-100, RUT-200, Celecoxib (CLX), and CLX + RUT-200 groups. The mice were weighed daily. After treatment, the animals were euthanized and segments of the small intestine were collected to evaluate histopathological alterations (morphometric analysis); malondialdehyde (MDA), myeloperoxidase (MPO), and glutathione (GSH) concentrations; mast and goblet cell counts; and cyclooxygenase-2 (COX-2) activity, as well as to perform immunohistochemical analyses. RUT treatment (200 mg/kg) prevented 5-FU-induced histopathological changes and reduced oxidative stress by decreasing MDA concentrations and increasing GSH concentrations. RUT attenuated the inflammatory response by decreasing MPO activity, intestinal mastocytosis, and COX-2 expression. These results suggest that the COX-2 pathway is one of the underlying protective mechanisms of RUT against 5-FU-induced intestinal mucositis.

1 November 2013 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
LPLúcio Fernandes Pires
Lúcio Fernandes Pires
LCLuciana Muratori Costa
Luciana Muratori Costa
OSOskar Almeida Silva
Oskar Almeida Silva
AAAntonia Amanda Cardoso de Almeida
Antonia Amanda Cardoso de Almeida
GCGilberto Santos Cerqueira
Gilberto Santos Cerqueira
RFRivelilson Mendes de Freitas
Rivelilson Mendes de Freitas

15 November 2019 in European Journal of Nutrition
Verified
Journal Article
Open access
PDF file
LTLydiane de Lima Tavares Toscano
Lydiane de Lima Tavares Toscano
Alexandre SilvaAlexandre Silva
Alexandre Silva
AFAna Carla Lima de França
Ana Carla Lima de França
BSBruno Rafael Virgínio de Sousa
Bruno Rafael Virgínio de Sousa
EFEder Jackson Bezerra de Almeida Filho
Eder Jackson Bezerra de Almeida Filho
MGMaria da Conceição Rodrigues Gonçalves
Maria da Conceição Rodrigues Gonçalves
Purpose: To investigate the effects of a single dose of juice on physical performance, oxidative stress, inflammation and muscle damage in runners.Methods: Fourteen recreational male runners (39 ± 9 years,VO2peak = 55.9 ± 6.5 ml/kg/min) performed two running tests to exhaustion at 80% ofVO2maxafter ingesting grape juice or a placebo drink (10 ml/kg/day) randomly. Blood samples were taken before and 2 h after supplementation and immediately after running to analyze total antioxidant capacity (TAC), malondialdehyde (MDA), alpha-1 acid glycoprotein (A1GPA), high-sensitivity C-reactive protein (hs-CRP), creatine kinase (CK) and lactate dehydrogenase (LDH).Results: The participants ran for an average of 59.2 ± 27.8 min until exhaustion in the placebo group and for 68.4 ± 29.7 min until exhaustion in the grape juice intake group, which was a significantly longer time (p = 0.008). This improvement in physical performance was accompanied by a 43.6% increase in TAC (p = 0.000) at the post-exercise timepoint compared to the level at baseline. MDA, A1GPA, hs-CRP, CK, and LDH did not exhibit changes. In contrast, no significant change in any variable was observed after consuming the placebo drink.Conclusion: The single-dose intake of purple grape juice demonstrated an ergogenic effect in recreational runners by increasing run time to exhaustion and increasing antioxidant activity.